An investigational typhoid vaccine containing a component developed with NIAID funding may overcome some of the shortcomings of available typhoid vaccines, according to a paper published in the journal Vaccine in June.
News - VaccineNation
PDF) Analysis of strategies to successfully vaccinate infants in
Frontiers The combination of vaccines and adjuvants to prevent
Frontiers Progress and Pitfalls in the Quest for Effective SARS
NIAID workshop on secondary vaccine effects
PDF) Adjuvanted Fusion Protein Vaccine Induces Durable Immunity to
Salmonella enterica serovar Typhi live vector vaccines finally
Frontiers Reduced immunogenicity of a live Salmonella enterica
World experts to gather for IVI symposium on hepatitis E – IVI